Cybin completes acquisition of small pharma inc. to create international clinical-stage leader in novel psychedelic therapeutics

Toronto & london--(business wire)--cybin inc. (nyse american:cybn) (neo:cybn) (“cybin”, or the “company”) and small pharma inc. (tsxv:dmt) (otcqb:dmttf) (“small pharma”) are pleased to announce the completion of the previously-announced acquisition by cybin of small pharma by way of a plan of arrangement under the business corporations act (british columbia), and pursuant to the terms of an arrangement agreement dated august 28, 2023 between cybin and small pharma (the “arrangement”). as a resu.
CYBN Ratings Summary
CYBN Quant Ranking